The Poliwogg Medical Indexes are designed to serve as fair, impartial and transparent measures of the performance of medical equities. There are currently three indexes in the Poliwogg Medical Index family:
Key defining factors include:
Poliwogg Medical Indexes represent breakthroughs in “smart beta” index methodologies. Poliwogg Medical Indexes apply metrics that are specific to biotechnology and pharmaceuticals and are not applicable to other sectors or industries, resulting in highly idiosyncratic performance characteristics.
Poliwogg Medical Indexes focus on companies that are principally engaged in the US health care sector, with strong emphasis on the dynamic small/mid-capitalization biotechnology segment.
All Poliwogg Medical Indexes depend on clearly defined rules based methodologies, which are overseen by an impartial Index Committee. No discretion is exercised in compiling the indexes and a pre-defined screening protocol assures a consistent, transparent and arms-length compilation process.